Drug
Dorzagliatin clinical trials
Also written HMS5552.
- studies test it
- 23
- open now
- 4
- in phase 3
- 3
- first study started
- 2013
Keep track of what changes. Save the Dorzagliatin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 13
- Phase 2
- 4
- Phase 3
- 3
- Phase 4
- 1
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 8
Hua Medicine Limited (15) · Chinese University of Hong Kong (3) · University of Alabama at Birmingham (1) · Elaine Chow (1) · Yan Bi (1) · Michael R. Rickels, MD, MS (1) · Sun Yat-sen University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Dorzagliatin is read from its arms, and is right about nine times in ten.
Testing it · 23
- Dorzagliatin in Pancreatic Insufficient Cystic FibrosisRecruitingPhase 1Michael R. Rickels, MD, MSNCT06995651Written as Dorzagliatin
- Glucokinase Activator in Monogenic DiabetesRecruitingPhase 2Chinese University of Hong KongNCT06976658Written as Dorzagliatin
- Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 DiabetesNot yet recruitingNot applicableElaine ChowNCT06671340Written as Dorzagliatin
- Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.Not yet recruitingNot applicableYan BiNCT06222476Written as Dorzagliatin
- Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal InsufficiencyWithdrawnNot applicableSun Yat-sen UniversityNCT07786571Written as Dorzagliatin
- A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 DiabetesCompletedPhase 4Hua Medicine LimitedNCT06263348Written as Dorzagliatin tablets
- Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase ActivityActive, not recruitingPhase 3University of Alabama at BirminghamNCT05098470Written as Dorzagliatin
- Drug Interaction Study Between Dorzagliatin and EmpagliflozinCompletedPhase 1Hua Medicine LimitedNCT03790787Written as Dorzagliatin
- Drug Interaction Study Between Dorzagliatin and SitagliptinCompletedPhase 1Hua Medicine LimitedNCT03790839Written as Dorzagliatin
- A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy VolunteersCompletedPhase 1Hua Medicine LimitedNCT04426708Written as HMS5552
- Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGTStatus unknownPhase 1/2Chinese University of Hong KongNCT05468229Written as Dorzagliatin
- Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic DiabetesCompletedPhase 2Chinese University of Hong KongNCT04531631Written as Dorzagliatin
- Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM SubjectsCompletedPhase 3Hua Medicine LimitedNCT03141073Written as HMS5552
- Long-term Efficacy and Safety of HMS5552 in T2DM SubjectsCompletedPhase 3Hua Medicine LimitedNCT03173391Written as HMS5552
- A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy VolunteersCompletedPhase 1Hua Medicine LimitedNCT04324424Written as HMS5552
- A Multi-center 12-week Study of HMS5552 in T2DMCompletedPhase 2Hua Medicine LimitedNCT02561338Written as HMS5552
- DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of DorzagliatinCompletedPhase 1Hua Medicine LimitedNCT04080596Written as Dorzagliatin
- DDI Study Between Dorzagliatin and RifampicinCompletedPhase 1Hua Medicine LimitedNCT04080609Written as Dorzagliatin
- Human Mass Balance Study of HMS5552 in Healthy SubjectsCompletedPhase 1Hua Medicine LimitedNCT03158506Written as HMS5552
- A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy VolunteersCompletedPhase 1Hua Medicine LimitedNCT01952535Written as HMS5552
Codes
What other systems call Dorzagliatin · ClinicalTrials.gg INT001045
- MeSH (NLM) C000629807DorzagliatinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) X59W6980E8DORZAGLIATINConfirmed FDA, NLM, Wikidata
- Wikidata Q76754209dorzagliatinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169919DorzagliatinOne source FDA
- DrugBank DB15123One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000629807 | Dorzagliatin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | X59W6980E8 | DORZAGLIATIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q76754209 | dorzagliatin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169919 | Dorzagliatin | One source FDA |
| DrugBank | DB15123 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.